Zolgensma
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for Zolgensma, covering 2020-07-16 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Zolgensma (onasemnogene abeparvovec) — Novartis Europharm Limited